Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid and advanced skin cancer. This FDA recap highlights recent approvals in April ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its wholly-owned subsidiary T-mab has entered into an agreement with Qilu Pharmaceutical for ...

Panelists discuss the promising results of the ReNeu trial for mirdametinib, highlighting its significant tumor shrinkage and ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has dosed its first patient in the ...

The typical Veklury dosage for adults with COVID-19 is 200 mg on day 1 followed by 100 mg once per day. The length of treatment can vary between 3 to 10 days. See the table below for details.

RP-HPLC method development and validation for estimation of rivaroxaban in pharmaceutical dosage forms. ... MISSELWITZ, F. Rivaroxaban: A novel, oral, direct factor Xa inhibitor in clinical ...

This study assessed the comparative pharmacokinetics of a novel prolonged release dosage form of lithium citrate in inbred mouse Unes BALB/c after single intragastrically administration. In the ...